New hope for transplant patients fighting cancer
Disease control
Recruiting now
This study is testing whether combining two antibody drugs, tafasitamab and rituximab, works better as a first treatment for lymphoma that develops after an organ transplant. It will involve 28 adult patients who have had a solid organ transplant and developed this specific cance…
Phase: PHASE2 • Sponsor: Timothy Voorhees • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC